Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
fever; swelling; freezing to death; head hurts; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Varicella zoster vaccine with an associated reaction of pain in extremity (Patient received first dose on an unknown date). On 17-JAN-2025, the patient received the 2nd dose of Shingles vaccine. In JAN-2025, less than a week after receiving Shingles vaccine, the patient experienced fever (Verbatim: fever), swelling (Verbatim: swelling), feeling cold (Verbatim: freezing to death) and headache (Verbatim: head hurts). The outcome of the fever, swelling, feeling cold and headache were not resolved. It was unknown if the reporter considered the fever, swelling, feeling cold and headache to be related to Shingles vaccine. It was unknown if the company considered the fever, swelling, feeling cold and headache to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 18-JAN-2025 This case was reported by a patient via interactive digital media. The follow-up could not be possible as no contact details were available. Patient received second one dose of vaccine and got a fever, swelling, and stated that he/she was freezing to death, head was hurting, also said that he/she was warned about this.